For example, in the case of lindane, it was known as early as 1991 from the extensive scientific literature already available that it was one of the substances which would not satisfy the requirements of the Directive. Why, then, was it subjected to the evaluation procedure?
Pour ce qui est du lindane, par exemple, on savait, déjà en 1991, au vu de l'abondante littérature scientifique à son sujet, qu'il faisait partie des substances qui ne rencontrent pas les exigences de la directive.